U-PLEX Diabetes Combo 1 (human)

Application(s)		Metabolic
Analyte(s)		C-Peptide, GIP (total), GLP-1 (total), Glucagon, Insulin, Leptin, PYY (total)
Species		Human
Instrument(s)		MESO SECTOR S 600MM , MESO QuickPlex SQ 120MM , MESO SECTOR S 600 , MESO QuickPlex SQ 120 , SECTOR Imager 6000 , SECTOR Imager 2400
U-PLEX Group Compatibility		Metabolic Group 1
Plate Type		96-well
Sample Type		EDTA Plasma, Serum, P800 Plasma
Usage Statement		For Research Use Only. Not for use in diagnostic procedures.
Storage Statement(s)		Please refer to the product insert for the storage conditions of individual kit components.
Storage Condition		Multi-Component
Schedule B Code		3822.19.0000

Product Description

Storage

Quantity per Kit

Human Diabetes Combo 1, Box 2 of 2 (1 PL)

Multi-Component

1 each
(1 plate size)

U-PLEX Linker Set, 1-Assay (300 μL)	2-8 °C	1 each (1 vial)
U-PLEX Glucagon Antibody Set	2-8 °C	1 each (1 plate size)
Calibrator 13	2-8 °C	1 vial (1 vial)
U-PLEX 2-Assay, 96-Well SECTOR Plate	2-8 °C	1 each (1 plate)
U-PLEX Stop Solution	2-8 °C	1 bottle (40 mL)
Diluent 11	≤-10 °C	1 bottle (10 mL)
Diluent 13	≤-10 °C	1 bottle (10 mL)
MSD GOLD Read Buffer B	RT	1 bottle (18 mL)
Aprotinin	2-8 °C	1 vial (50 μL)

Product Description

Storage

Quantity per Kit

Human Diabetes Combo 1, Box 2 of 2 (5 PL)

Multi-Component

1 each
(5 plate size)

U-PLEX Linker Set, 1-Assay (1.8 mL)	2-8 °C	1 each (1 vial)
U-PLEX Glucagon Antibody Set	2-8 °C	1 each (5 plate size)
Calibrator 13	2-8 °C	5 vial (1 vial)
U-PLEX 2-Assay, 96-Well SECTOR Plate	2-8 °C	5 each (1 plate)
U-PLEX Stop Solution	2-8 °C	1 bottle (40 mL)
Diluent 11	≤-10 °C	1 bottle (50 mL)
Diluent 13	≤-10 °C	1 bottle (50 mL)
MSD GOLD Read Buffer B	RT	1 bottle (90 mL)
Aprotinin	2-8 °C	1 vial (250 μL)

Product Description

Storage

Quantity per Kit

Human Diabetes Combo 1, Box 2 of 2 (25 PL)

Multi-Component

1 each
(25 plate size)

U-PLEX Linker Set, 1-Assay (1.8 mL)	2-8 °C	5 each (1 vial)
U-PLEX Glucagon Antibody Set	2-8 °C	5 each (5 plate size)
Calibrator 13	2-8 °C	25 vial (1 vial)
U-PLEX 2-Assay, 96-Well SECTOR Plate	2-8 °C	25 each (1 plate)
U-PLEX Stop Solution	2-8 °C	5 bottle (40 mL)
Diluent 11	≤-10 °C	5 bottle (50 mL)
Diluent 13	≤-10 °C	5 bottle (50 mL)
MSD GOLD Read Buffer B	RT	5 bottle (90 mL)
Aprotinin	2-8 °C	5 vial (250 μL)

Product Inserts		U-PLEX Metabolic Group 1 (human) Multiplex Insert
Datasheets		U-PLEX Human C-Peptide U-PLEX Human GIP (total) U-PLEX Human GLP-1 (total) U-PLEX Human Glucagon U-PLEX Human Insulin U-PLEX Human Leptin U-PLEX Human PYY (total)
Product Highlights		U-PLEX Platform Highlights
SDS		Biotin-conjugated Antibodies Safety Data Sheet Diluent 10, Diluent 11, Diluent 12, Diluent 13, Diluent 15, Diluent 16 and Diluent 17 MSD Calibrators and Controls MSD GOLD Read Buffer B U-PLEX Linker Set

Title	Journal	Year
Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops Ilaria Marzinotto, David L Pittman, Alistair J K Williams, Anna E Long, Peter Achenbach, Michael Schlosser, Beena Akolkar, William E Winter, Vito Lampasona; participating laboratories	Diabetologia	2023
Leptin levels are associated with multiple sclerosis risk Biström M, Hultdin J, Andersen O, Alonso-Magdalena L, Jons D, Gunnarsson M, Vrethem M, Sundström P	Multiple Sclerosis	2020
Genetic Deletion and Pharmacological Inhibition of Phosphodiesterase 10A Protects Mice From Diet-Induced Obesity and Insulin Resistance. Nawrocki AR, Rodriguez CG, Toolan DM, Price O, Henry M, Forrest G, Szeto D, Keohane CA, Pan Y, Smith KM, Raheem IT, Cox CD, Hwa J, Renger JJ, Smith SM.	Diabetes	2014
A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study. Hirata S, Dirven L, Shen Y, Centola M, Cavet G, Lems WF, Tanaka Y, Huizinga TW, Allaart CF.	Rheumatology (Oxford)	2013
Beneficial effects of parenteral GLP-1 delivery by cell therapy in insulin-deficient streptozotocin diabetic mice. Vasu S, Moffett RC, McCluskey JT, Hamid MH, Irwin N, Flatt PR.	Gene Ther.	2013
View All